THE USE OF EXTENDED RELEASE BUPIVACAINE WITH TRANSVERSUS ABDOMINIS PLANE AND SUBCOSTAL ANTERIOR QUADRATUS LUMBORUM CATHETERS: A RETROSPECTIVE ANALYSIS OF A NOVEL TECHNIQUE

The use of extended release bupivacaine with transversus abdominis plane and subcostal anterior quadratus lumborum catheters: A retrospective analysis of a novel technique

Background and Aims: Liposomal bupivacaine (LB) is a formulation of local anesthetic that may exert analgesia over a prolonged period.Anecdotal use of LB suggests benefit and prolonged analgesia when used to supplement Food Toppers infiltration blocks.Our aim was to test the effect of a bolus of LB delivered through a nerve catheter in two types of

read more

o-Nitroaryl-bis(5-methylfur-2-yl)methanes as Versatile Synthons for the Synthesis of Nitrogen-Containing Heterocycles

2-Nitroaryldifurylmethanes 1a and 1b, readily available by condensation of 2-nitrobenzaldehyde and 6-nitroveratraldehyde with 2-methylfuran, were transformed into indole, cinnoline and benzothiazine-3,1 JAWS SECTIONING CLIPS derivatives.The reduction of 2-nitroaryldifurylmethanes gave the corresponding anilines 2a,b or indole 3 depending on the rea

read more


Organizational Cultures of Vocational Schools and Enterprises in Russia, China and Iran as Perceived by Students and Teachers

This study examines the problems of getting vocational students prepared to work for a modern innovative enterprise and ensure their organizational socialization within the changing technological paradigm.Research methodology was based on the organizational culture framework proposed by Kim S.Cameron and Robert E.Quinn.A survey was conducted to fin

read more

PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration

The alternative pathway of the complement system is implicated in the etiology of age-related macular degeneration (AMD).Complement depletion with pegcetacoplan and avacincaptad pegol are FDA-approved treatments for geographic atrophy in AMD that, while effective, have clinically observed risks of choroidal neovascular (CNV) conversion, optic neuri

read more